EUROLAB laboratory provides testing and compliance service within the scope of USP 63 standard. This standard specifies the requirements for the mycoplasma detection test.
Mycoplasma are the smallest self-replicating organisms known to exist. More than 100 different species have been described to date. Therapeutic products for human or veterinary use require screening for mycoplasma.
At various stages in their production, for example: cell banking, virus seed stock preparation, raw batch harvesting, raw material use and final product release.
Mycoplasma contamination of cell culture is a serious concern for the biopharmaceutical industry. The organism may compromise the safety of the derived eukaryotic cell culture.
It is known that biological products derived from components of cell culture media such as serum or all animal species, individuals working in a laboratory or manufacturing facility, allow mycoplasma infection.
EUROLAB assists manufacturers with USP 63 test compliance. Our test experts, with their professional working mission and principles, provide you, our manufacturers and suppliers, the best service and controlled testing process in our laboratories. Thanks to these services, businesses receive more effective, high-performance and quality testing services and provide safe, fast and uninterrupted service to their customers.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
EUROLABreporting and certification activities, United Accreditation Foundation (UAF), Turkish Accreditation Agency (TÜRKAK) ve Enterprise Accreditation Foundation (EAF) based on the accreditation provided by the accreditation body. The Enterprise Accreditation Foundation (EAF) accreditation body is also a signatory of the United Nations (UN GLOBAL COMPACT) organization.
